Paul Y. Song
Vorstandsvorsitzender bei NKGen Biotech, Inc.
Vermögen: 337 204 $ am 30.04.2024
Profil
Dr. Paul Song is a Chairman & Chief Executive Officer at NKGen Biotech, Inc. and a Chairman & Chief Executive Officer at NKGen Operating Biotech, Inc. He is on the Board of Directors at PeproMene Bio, Inc., Gideons Promise, Inc. and Mercy Corps.
Dr. Song was previously employed as a Chief Executive Officer & Director by Fuse Biotherapeutics, Inc. and a Chief Medical Officer by NKMAX Co., Ltd.
(South korea).
He received his undergraduate degree from The University of Chicago and a doctorate degree from George Washington University School of Medicine & Health.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
0,75% | 29.04.2024 | 170 305 ( 0,75% ) | 337 204 $ | 30.04.2024 |
Aktive Positionen von Paul Y. Song
| Unternehmen | Position | Beginn |
|---|---|---|
NKGen Biotech, Inc.
 NKGen Biotech, Inc. BiotechnologyHealth Technology NKGen Biotech, Inc. is a biotechnology company which engages in harnessing the immune system through natural killer cell therapies. It develops a proprietary stabilizing peptide, monoclonal antibodies, and recombinant proteins for research use. The company was founded in 2002 and is headquartered in Santa Ana, CA. | Vorstandsvorsitzender | 10.01.2023 |
PeproMene Bio, Inc.
 PeproMene Bio, Inc. Pharmaceuticals: MajorHealth Technology PeproMene Bio, Inc. engages in developing novel immune-oncology therapies. The company was founded in 2016 and is headquartered in Irvine, CA. | Direktor/Vorstandsmitglied | 01.03.2022 |
Mercy Corps
 Mercy Corps Services to the Health IndustryHealth Services Mercy Corps provides emergency relief and economic support services. The company makes a real impact in the lives of families in the world’s toughest places. The company was founded by Daninel W. O'Neill and Ellsworth Culver in November 1979 and is headquartered in Portland, OR. | Direktor/Vorstandsmitglied | - |
| Gideons Promise, Inc. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Paul Y. Song
| Unternehmen | Position | Ende |
|---|---|---|
Fuse Biotherapeutics, Inc.
 Fuse Biotherapeutics, Inc. BiotechnologyHealth Technology Fuse Biotherapeutics, Inc. is a biotechnology company based in Los Angeles, CA. Fuse Biotherapeutics is dedicated to developing transformative immune modulating therapeutics for patients with cancer. The company's therapeutic approach integrates the multiple steps of an immune response in a rational manner that targets potent responses to danger without sacrificing natural breaks in the system that spare healthy tissues. The company was founded by Jeffrey Kunio Takimoto, Geoffrey W. Smith, Y Song Paul, Evren Alici, Brian Rabinovich. | Gründer | 01.01.2023 |
| NKMAX CO., LTD. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2021 |
Ausbildung von Paul Y. Song
| The University of Chicago | Undergraduate Degree |
| George Washington University School of Medicine & Health | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| NKMAX CO., LTD. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Mercy Corps
Mercy Corps Services to the Health IndustryHealth Services Mercy Corps provides emergency relief and economic support services. The company makes a real impact in the lives of families in the world’s toughest places. The company was founded by Daninel W. O'Neill and Ellsworth Culver in November 1979 and is headquartered in Portland, OR. | Health Services |
PeproMene Bio, Inc.
PeproMene Bio, Inc. Pharmaceuticals: MajorHealth Technology PeproMene Bio, Inc. engages in developing novel immune-oncology therapies. The company was founded in 2016 and is headquartered in Irvine, CA. | Health Technology |
NKGen Biotech, Inc.
NKGen Biotech, Inc. BiotechnologyHealth Technology NKGen Biotech, Inc. is a biotechnology company which engages in harnessing the immune system through natural killer cell therapies. It develops a proprietary stabilizing peptide, monoclonal antibodies, and recombinant proteins for research use. The company was founded in 2002 and is headquartered in Santa Ana, CA. | Health Technology |
Fuse Biotherapeutics, Inc.
Fuse Biotherapeutics, Inc. BiotechnologyHealth Technology Fuse Biotherapeutics, Inc. is a biotechnology company based in Los Angeles, CA. Fuse Biotherapeutics is dedicated to developing transformative immune modulating therapeutics for patients with cancer. The company's therapeutic approach integrates the multiple steps of an immune response in a rational manner that targets potent responses to danger without sacrificing natural breaks in the system that spare healthy tissues. The company was founded by Jeffrey Kunio Takimoto, Geoffrey W. Smith, Y Song Paul, Evren Alici, Brian Rabinovich. | Health Technology |
| Gideons Promise, Inc. |
